Long-Term Treatment with Lenalidomide in Previously Treated Subjects with Multiple Myeloma

被引：0
|
作者：
Amor, A. A. [1 ]
Aguado, B. [1 ]
Camara, C. [1 ]
Velasco, A. [1 ]
Garcia-Escribano, F. [1 ]
机构：
[1] Hosp Univ Princesa, Dept Hematol, Madrid, Spain
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70580-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S68 / S69
页数：2
相关论文
共 50 条
  • [1] BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma
    Rossi, Adriana
    Mark, Tomer
    Jayabalan, David
    Christos, Paul
    Zafar, Faiza
    Pekle, Karen
    Pearse, Roger
    Chen-Kiang, Selina
    Coleman, Morton
    Niesvizky, Ruben
    BLOOD, 2013, 121 (11) : 1982 - 1985
  • [2] THE EXPERIENCE OF LONG-TERM LENALIDOMIDE THERAPY OF PATIENTS WITH FOR MULTIPLE MYELOMA
    Samoilova, O. S.
    Grishunina, M. E.
    Rastorguev, G. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2011, 56 (03): : 40 - 42
  • [3] Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment
    Manola Zago
    Katharina Oehrlein
    Corinna Rendl
    Corinna Hahn-Ast
    Lothar Kanz
    Katja Weisel
    Annals of Hematology, 2014, 93 : 1993 - 1999
  • [4] Lenalidomide in Relapsed and Refractory Multiple Myeloma Disease: Feasibility and Benefits of Long-Term Treatment
    Oehrlein, Katharina
    Rendl, Corinna
    Hahn-Ast, Corinna
    Kanz, Lothar
    Weisel, Katja C.
    BLOOD, 2012, 120 (21)
  • [5] Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment
    Zago, Manola
    Oehrlein, Katharina
    Rendl, Corinna
    Hahn-Ast, Corinna
    Kanz, Lothar
    Weisel, Katja
    ANNALS OF HEMATOLOGY, 2014, 93 (12) : 1993 - 1999
  • [6] Lenalidomide improves survival in previously treated patients with multiple myeloma
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (01): : 43 - 43
  • [7] Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
    Kourelis, T. V.
    Kumar, S. K.
    Srivastava, G.
    Gertz, M. A.
    Lacy, M. Q.
    Buadi, F. K.
    Kyle, R. A.
    Dispenzieri, A.
    LEUKEMIA, 2014, 28 (02) : 455 - 457
  • [8] Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
    T V Kourelis
    S K Kumar
    G Srivastava
    M A Gertz
    M Q Lacy
    F K Buadi
    R A Kyle
    A Dispenzieri
    Leukemia, 2014, 28 : 455 - 457
  • [9] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    M A Dimopoulos
    A S Swern
    J S Li
    M Hussein
    L Weiss
    Y Nagarwala
    R Baz
    Blood Cancer Journal, 2014, 4 : e257 - e257
  • [10] Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
    Dimopoulos, M. A.
    Swern, A. S.
    Li, J. S.
    Hussein, M.
    Weiss, L.
    Nagarwala, Y.
    Baz, R.
    BLOOD CANCER JOURNAL, 2014, 4 : e257 - e257
12345